Summary
We have routinely used a [3H]-uridine micro-plate assay for assessing chemosensitivity. A colorimetric assay with the advantages of safety, cost and simplicity has previously been described and relies on the ability of living cells to reduce a soluble tetrazolium salt, 3-4,5-dimethylthiazol-2,5-diphenyl-tetrazolium bromide (MMT), into an insoluble formazan precipitate. We compared the chemosensitivity of 14 human tumour cell lines of colonic, lung and cervical carcinoma origin to doxorubicin, vindesine or vindesine immunoconjugates in both the [3H]-uridine assay and a modified MTT assay to evaluate whether we could change to the non-radiolabelled method. Correlation between the concentration of drug causing 50% inhibition of cell growth (IC50) for these agents between the two assays was very poor. However, taking account of recent reports in the literature, we modified the MTT assay by removing serum-containing medium and using dimethyl sulphoxide to solubilise the formazan precipitate. This considerably improved the correlation between the assays for doxorubicin (r=0.871; P=0.001) and vindesine (r=0.981; P(0.001). Our data indicates that the MTT assay can be used to replace the [3H]-uridine assay for chemosensitivity screening, but further modifications are necessary to improve the sensitivity and decrease the problem of cell loss after washing, which was noted with some adherent cell lines.
Similar content being viewed by others
References
Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589
Carmichael J, Degraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47: 943
Cole SPC (1986) Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol 17: 259
Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89: 271
Ford CHJ, Bartlett SE, Casson AG, Marsden CH, Gallant ME (1987) Efficacy and specificity of vindesine monoclonal anti-carcinoembryonic antigen conjugate with nine human cancer cell lines. Natl Cancer Inst Monogr 3: 107
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol 65: 55
Park J-G, Kramer BS, Steinberg SM, Carmichael J, Collins JM, Minna JD, Gazdar AF (1987) Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res 47: 5875
Richardson VJ, Ford CHJ, Tsaltas G, Gallant ME (1989) Doxorubicin-anti-carcinoembryonic antigen immunocon-jugate activity in vitro. Eur J Cancer Clin Oncol (in press)
Rowland GF, Simmonds RG, Gore VA, Marsden CH, Smith W (1986) Drug localisation and growth inhibition studies of vindesine-monoclonal anti-CEA conjugates in a human tumour xenograft. Cancer Immunol Immunother 21: 183
Ruben RL, Neubauer RH (1987) Semiautomated colorimetric assay for in vitro screening of anticancer compounds. Cancer Treat Rep 71: 1141
Twentyman PR, Luscombe M (1987) A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56: 279
Wilson AP, Ford CHJ, Newman CE, Howell A (1987) Cisplatinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cisplatinum as first line treatment. Br J Cancer 56: 763
Author information
Authors and Affiliations
Additional information
Supported by grants from the Newfoundland Lung Association, the Faculty of Medicine Research and Development Committee and the Newfoundland Cancer Foundation.
Rights and permissions
About this article
Cite this article
Ford, C.H.J., Richardson, V.J. & Tsaltas, G. Comparison of tetrazolium colorimetric and [3H]-uridine assays for in vitro chemosensitivity testing. Cancer Chemother. Pharmacol. 24, 295–301 (1989). https://doi.org/10.1007/BF00304761
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00304761